Skip to main content

Advertisement

Table 1 Characteristic of study participants at inclusion by randomization group

From: Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes

Characteristics SP3 group (n = 649) SP2 group (n = 625)
Study location   
   Karaba village (n, %) 152 (23.42) 173(27.68)
   Koho village (n, %) 497 (76.58) 452(72.32)
Education   
   none (n, %) 576 (90.85) 528(86.70)
   primary (n, %) 45 (7.10) 66 (10.84)
   secondary and higher (n, %) 13 (2.05) 15 (2.46)
Ethnicity   
   bwaba (n, %) 160 (24.65) 165 (26.40)
   mossi (n, %) 423 (65.18) 400 (64.00)
   peuhl (n, %) 37 (5.70) 41 (6.56)
   other (n, %) 29 (4.47) 19 (3.04)
Occupation   
   farmer/housewife (n, %) 625(96.30) 609 (97.44)
   student (n, %) 2 (0.31) 6 (0.96)
   other (n, %) 4 (0.62) 5 (0.80)
   missing (n, %) 18 (2.77) 5 (0.80)
Parity   
   primigravidae (n, %) 130 (20.03) 135 (21.60)
   secundigravidae (n, %) 143 (22.03) 119 (19.04)
   multigravidae (n, %) 376 (57.94) 371 (59.36)
Gestation at enrolment   
   first trimester (n, %) 263 (40.52) 235 (37.60)
   second trimester (n, %) 345 (53.16) 343 (54.88)
   third trimester (n, %) 41 (6.32) 47 (7.52)
Age   
   mean (years) (95% CI) 24.26 (23.80-24.73) 24.66 (24.15-25.17)
Weight   
   mean (kg) (95% CI] 55.40 (54.86-55.94) 55.36 (54.82-55.92)
Height   
   mean (cm) (95% CI] 162.77 (162.32-163.25) 162.50 (162.04-162.96)
BMI at enrolment   
   mean (95% CI] 20.88 (20.72-21.04) 20.95 (20.77-21.13)
Prevalence of peripheral infection 114 (17.57%) 123 (19.68%)